Novel MAFLD criteria increases identification of fatty liver disease

Novel MAFLD criteria increases identification of fatty liver disease

Researchers identified more patients with fatty liver disease using novel metabolic dysfunction-associated fatty liver disease criteria compared with nonalcoholic fatty liver disease criteria.“Fatty liver disease (FLD) has become the most common chronic liver disease globally with prevalence of over 25% and one of the major causes for cirrhosis and hepatocellular carcinoma,” Laurens van Kleef, MS, Erasmus MC, University Medical Center, Rotterdam, the Netherlands, said at the Digital NAFLD Summit 2021. “Recently, a transition from NAFLD to metabolic dysfunction-associated FLDRead More

Share on facebook
Share on twitter
Share on linkedin